Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as registration number 188062-50-2, is a potent HIV medication. It blocks the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme plays a vital role in the HIV life cycle, facilitating the virus to insert its genetic material into the host

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor utilized in the therapy of human immunodeficiency virus syndrome. Its therapeutic properties stem from the potent inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a metabolite that undergoes transformation to its active form, carbovir

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. Top-rated global API manufacturer and supplier provides a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and c

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor. Its mechanism of action involves the competitive ASPIRIN 50-78-2 blocking of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its effects by being incorporated into the growing DNA chain during reverse transcription, leading to prem

read more

The Premier Nutraceutical API Manufacturer

India has firmly established itself as a global hub for wellness ingredient manufacturing, particularly in the realm of Active Pharmaceutical Ingredients (active ingredients). Numerous local firms specialize in the specialized production of wellness APIs, serving both the local market and exporting globally. These businesses boast advanced capabili

read more